标题
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 3, Pages 333-347
出版商
Informa Healthcare
发表日期
2012-11-16
DOI
10.1517/17425255.2013.737319
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity
- (2012) A Shimoni et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children
- (2012) Angelo Paci et al. THERAPEUTIC DRUG MONITORING
- Fludarabine and Pharmacokinetic-Targeted Busulfan before Allografting for Adults with Acute Lymphoid Leukemia
- (2011) Stella Santarone et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience
- (2011) M. A. Slatter et al. BLOOD
- Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party
- (2011) J Wachowiak et al. BONE MARROW TRANSPLANTATION
- Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial
- (2011) T. Ruutu et al. HAEMATOLOGICA
- Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
- (2011) Joseph Pidala et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- HPLC method for determination of biologically active epoxy-transformers of treosulfan in human plasma: Pharmacokinetic application
- (2011) Franciszek K. Główka et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Weight-based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results
- (2011) Gérard Michel et al. PEDIATRIC BLOOD & CANCER
- High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients
- (2011) Blanca Molina et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- (2010) Eneida R. Nemecek et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring
- (2010) J. Gaziev et al. BLOOD
- Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
- (2010) N Cantoni et al. BONE MARROW TRANSPLANTATION
- High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation
- (2010) Franciszek K Główka et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
- (2010) Jochen Casper et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation
- (2009) Imke H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Busulfan in Hematopoietic Stem Cell Transplantation
- (2009) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan, Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous Leukemia
- (2009) James A. Russell et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide
- (2009) Robert M. Dean et al. BRITISH JOURNAL OF HAEMATOLOGY
- Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients
- (2009) F. Léger et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Busulfan in hematopoietic stem cell transplant setting
- (2009) Jeannine S McCune et al. Expert Opinion on Drug Metabolism & Toxicology
- Preclinical analysis of treosulfan in combination with total body irradiation as conditioning regimen prior to bone marrow transplantation in rats
- (2009) Vicky Sender et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Long‐term results of survival in patients with thalassemia major treated with bone marrow transplantation
- (2008) Paolo Di Bartolomeo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients
- (2008) Donatella Baronciani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide
- (2008) Christopher N. Bredeson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS
- (2008) Borje S. Andersson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT
- (2008) F K Główka et al. BONE MARROW TRANSPLANTATION
- The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
- (2008) B Sadeghi et al. BONE MARROW TRANSPLANTATION
- Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation
- (2008) Rob Cutting et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia
- (2008) Jerzy Holowiecki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities
- (2008) Brigit Greystoke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients
- (2008) Doreen Munkelt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation
- (2007) Imke H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now